Amerisource Health Services recalls GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx…
- Recall date
- February 3, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0520-2017
- FDA classification
- Class II
- Brand / firm
- Amerisource Health Services
- Sold / distributed
- Nationwide
Why it was recalled
Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21
Get recall alerts
Free email alert whenever Amerisource Health Services has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Amerisource Health Services